Lewis rats immunized with P 2 protein, a 14.5-kDa protein of the peripheral nerve myelin, develop experimental allergic neuritis, a paralytic disorder with clinical, histologic, and electrophysiologic features similar to those of human Guillain-Barré syndrome (GBS). T cells reactive to P 2 protein or a peptide corresponding to 53-78 residues of the protein can transfer the disease to naive animals. The mechanisms by which these T cells induce demyelination are not well understood; however, they may induce inflammation and demyelination in the nerves by production of Th1 cytokines. Th2 cytokines may lead to suppression of the inflammation and eventual recovery. There is no conclusive evidence that P 2 protein plays a role in the pathogenesis of GBS, with or without association with Campylobacter jejuni; however, studies of the immunopathogenesis of P 2 proteininduced experimental allergic neuritis are important for understanding the pathogenesis of inflammatory demyelination in the peripheral nerves, the hallmark of GBS.
The search for the cause of Guillain-Barré syndrome (GBS) vitro and can transfer EAN to naive syngeneic rats [7, 8] has been a long and arduous process. Various viruses and (figure 1). The recipient rats do not show antibodies to these bacteria have been implicated in the etiology of the disease, antigens. Systemic injection of the sera from these animals either directly or through presumed antigenic mimicry and audoes not induce demyelination in the PNS; however, intraneutoimmunity; however, a cause-and-effect relationship has not ral injection (thereby bypassing the blood-nerve barrier) of been established.
high-titer anti-P 2 serum can induce demyelination in the sciThe autoimmune theory of causation of GBS was first proatic nerve of rats [9] . Systemic injection of antibody to galacposed in 1995, mainly by analogy to experimental allergic tocerebroside, a glycolipid component of the myelin sheath, neuritis (EAN; an animal model of GBS) induced in rodents in addition to reactive T cells into Lewis rats produces severe by immunization with peripheral nerve tissues in complete demyelination in the PNS. The demyelination is greater than Freund's adjuvant [1, 2] . Over the ensuing years, the search that produced by SP 26 -reactive T cells alone, suggesting a for the antigen in the peripheral nerve led to the discovery of synergistic role of T cell autoimmunity and humoral response P 2 protein of the peripheral nerve myelin as the main antigen in the inflammatory demyelination of Lewis rat EAN [10] . responsible for the induction of EAN [3, 4] . P 2 protein is a Activated T cells nonreactive to neural antigens have also component of the peripheral nervous system (PNS) myelin and been shown to open the blood-nerve barrier to circulating has a molecular mass of 14.5 kDa. It is comprised of 131 demyelinating antibodies [11] . amino acids [3, 5] .
The clinical course of EAN induced by active immunization with P 2 or SP 26 is different from that of EAN induced by passive transfer of P 2 -or SP 26 -reactive T cells. Typically, in P 2 -Reactive T Cells in EAN active EAN in the Lewis rat, the disease starts Ç10 days after P 2 protein, when mixed with complete Freund's adjuvant immunization, peaks around day 16, and resolves by day 30. and injected subcutaneously into Lewis rats, produces a paraIn passive EAN in the Lewis rat, the disease starts earlier, lytic disorder with histologic and electrophysiologic features usually on day 4, peaks around day 8, and resolves by day similar to those of GBS [4] . A synthetic peptide corresponding 20 after the transfer of P 2 -or SP 26 -reactive T cells [8] (figure to residues 53-78 of bovine P 2 protein (SP 26 ) has also been 2). These T cells can undergo apoptosis in situ and terminate shown to produce EAN in Lewis rats [6] . Lymph node cells the autoimmune attack on the nerve [12] . P 2 -or SP 26 -reactive from P 2 -or SP 26 -immunized rats respond to these antigens in T cells capable of transferring EAN are CD4 / T cells, and preliminary observation suggests that they are of the Th1 subtype [8] .
The exact mechanism by which P 2 -reactive T cells cause and recovery from the disease could result from action of inhib-S161 JID 1997;176 (Suppl 2) T Cell Reactivity to P 2 Protein the axons when the nerve milieu becomes less inflammatory, but what factors suppress the inflammation in the nerve? T cells can undergo apoptosis in situ and gradually terminate the autoimmune attack on the nerve [12] . Alternatively or concomitantly, the shift of balance of the inflammatory cells in the nerves may favor a Th2 response that can counteract the effect of Th1 cytokines, such as INF-g, and suppress the inflammation. My colleagues and I did a longitudinal study on two major Th2 cytokines, interleukin (IL)-10 and IL-4, in active EAN [15] . Using quantitative RT-PCR, we measured the amount of message for these cytokines at different time points, from immunization to recovery, during EAN. There was a slight decrease in IL-10 expression at day 10 after immunization, which corresponded with days 1 -2 before clinical onset, when there was an increase in IFN-g message. IL-10 production, like IFN-g production, reached maximum at day 16 after immunization. No IL-4 message could be detected in the nerves during the course of EAN or in control rat nerves. IL-10 is a potent suppressor of macrophages, T cells, and NK cells. It suppresses the transformation and growth of Th1 cells and production of IFN-g by those cells. It also suppresses the production of tumor necrosis factor-a, IL-6, granulocyte-macrophage colony-stimulating factor, and IL-10 itself [18, 19] .
IL-10 has been shown to suppress clinical EAN in rats [20] . Therefore, the rise in IL-10 at the height of clinical EAN can be viewed as an attempt by Th2 cells to down-regulate the proinflammatory cytokines and lead to recovery from EAN.
Other antiinflammatory cytokines, such as transforming Based on the observation that P 2 proteins can induce EAN and P 2 -reactive T cells can transfer the disease, several laboratories have studied the potential of P 2 protein as an antigen in GBS or chronic inflammatory demyelinating polyneuropathy. lel with the clinical course of EAN, and positive IFN-g immunoreactivity in the cauda equina was shown at the peak of A mild degree of cell-mediated immunity to P 2 protein in GBS has been reported in some studies [24 -26] but not in others clinical disease [14] .
Recently, using quantitative reverse transcriptase -polymer-[27, 28]. P 2 -reactive T cells can be isolated from GBS and normal ase chain reaction (RT-PCR), my colleagues and I demonstrated that the expression of IFN-g message in the cauda subjects by in vitro sensitization, using P 2 protein in the culture medium [29] . These observations suggest that some autoreacequina of rats with EAN starts to increase prior to the onset of clinical disease [15] . This increase parallels the rise in the tive T cells are not entirely deleted from the repertoire during immunologic maturation. severity of clinical paralysis. The main source of IFN-g at this stage of the disease is most likely Th1 cells infiltrating the Is there a role for T cells reactive to P 2 protein or other PNS antigens in C. jejuni -associated GBS? There are no studies to nerves, although nonimmune cells within the peripheral nerves, such as Schwann cells, produce cytokines [16, 17] . It is possible specifically address this question. However, one can assume that C. jejuni infection, perhaps through antigenic mimicry and that the macrophages that have infiltrated the nerves become activated by IFN-g and damage the myelin sheath.
induction of an autoimmune response, can damage the PNS myelin. This process can release P 2 and other proteins and Most animals actively immunized and passively transferred with P 2 -reactive T cells recover from EAN. The mechanism nonprotein antigens from the damaged myelin sheath. Immune response against these antigens, which are normally hidden of this recovery is not clear. Schwann cells can remyelinate behind the relatively immunologically privileged blood-nerve an important role in the process of demyelination. Deposition of complement on Schwann cells in the demyelinating form of barrier, can generate another autoimmune attack against the PNS myelin and produce further inflammation and demyelin-GBS [32] and on axolemma in acute motor axonal neuropathy associated with C. jejuni infection [33] has been reported. ation. T cells reactive to the myelin antigens can either directly (most likely through cytokines) damage the myelin or increase Association of C. jejuni infection with GBS is an intriguing observation. Further studies on the role of this bacterium in the permeability of the blood-nerve barrier, thereby allowing humoral factors to gain access to the nerve and produce demye-GBS and establishment of a cause-and-effect relationship can lead to a better understanding of the pathogenesis of GBS, lination.
Patients with GBS and C. jejuni infection often have higheven in the cases not associated with this infection. titer antibody to the bacteria. These antibodies may cross-react with GM 1 ganglioside, a component of PNS myelin [30, 31] .
